去肾交感神经术减轻慢性肾脏病大鼠的心肾损伤OA
Renal sympathetic denervation alleviates cardiac and renal damage in rats with chronic kidney disease
目的 观察去肾交感神经术(RSD)对慢性肾脏病(CKD)大鼠的心肾保护作用.方法 将 30 只SD大鼠随机分为 5 组(每组 6 只):假手术组、5/6 肾切除模型组、RSD组、美托洛尔组、培哚普利组.分别于实验第 4、8 周测量尾动脉收缩压(SBP)和心率;行心脏超声评估左心室舒张末期后壁厚度(LVPWd)、舒张末期室间隔厚度(IVSTd)、左心室射血分数(LVEF)及左心室质量(LV mass).收集血液及尿液检测尿蛋白(UP)、肌酐(Cr)、尿素氮(BUN)、尿酸(UA)、脑钠肽(BNP);并于第 8 周取心、肾组织行 Masson染色观察纤维化程度,ELISA法检测血清 IL-1β、IL-6、TNF-α、TGF-β1 水平,Western blot检测心肌组织Smad2/3、p-Smad2/3、α-SMA、Collagen1、TGF-β1 蛋白表达.结果 与假手术组比较,模型组SBP、IVSTd、LVPWd、LV mass及UP、Cr、BUN、UA、BNP水平均显著升高,LVEF及肾脏体积(K Vol)降低(均P<0.05).与模型组比较,各干预组(RSD、美托洛尔、培哚普利)SBP、IVSTd、LVPWd、LV mass均降低,LVEF改善,UP、Cr、BUN、UA、BNP水平降低(P<0.05).模型组血清 4 种炎性因子水平均升高,各干预组IL-6、TGF-β1水平较模型组降低(P<0.05).心脏与肾脏Masson染色显示模型组纤维化明显,各干预组纤维化程度减轻.模型组心肌酪氨酸羟化酶(TH)染色范围扩大,各干预组TH染色范围减小.Western blot 显示模型组 TGF-β1、p-Smad2/3、α-SMA、Collagen1表达上调,各干预组上述蛋白表达均下降(P<0.05).结论 去肾交感神经术通过减轻纤维化和抑制IL-6/TGF-β1介导的炎症反应,缓解慢性肾脏病大鼠的心肾损伤.
Objective To investigate the cardiorenal protective effects of renal sympathetic denervation(RSD)in rats with chronic kidney disease(CKD).Methods Rats were divided into five groups(n=6 per group):sham-operated group,5/6 nephrectomy-induced chronic kidney injury(CKI)model group,RSD group,meto-prolol group,and perindopril group.Systolic blood pressure(SBP)and heart rate were measured noninvasively using the tail-cuff method at weeks 4 and 8.Cardiac ultrasonography was performed to assess left ventricular end-diastolic posterior wall thickness(PWTd),interventricular septal thickness at end-diastole(IVSTd),ejection fraction(LVEF),and left ventricular mass(LV mass).Blood and urine samples were collected for biochemical analysis.At week 8,heart and kidney tissues were collected for histopathological examination.Masson's trichrome staining was used to evaluate cardiac and renal fibrosis.Serum levels of IL-1β,IL-6,TNF-α,and TGF-β1 were measured by ELISA.Protein expression of Smad2/3,p-Smad2/3,α-SMA,Collagen1,and TGF-β1 in cardiac tissue was an-alyzed by Western blot.Results Compared with the sham group,the model group exhibited significantly elevated SBP,increased IVSTd,LVPWd,and LV mass,higher levels of urinary protein(UP),creatinine(Cr),blood u-rea nitrogen(BUN),uric acid(UA),and brain natriuretic peptide(BNP)and reduced LVEF as well as kidney volume(K Vol)(all P<0.05).In contrast,all intervention groups(RSD,metoprolol,perindopril)exhibited sig-nificant reductions in SBP,IVSTd,LVPWd,LV mass,and lower levels of UP,Cr,BUN,UA,and BNP,as well as improved LVEF compared to the model group(P<0.05).The model group had elevated serum level of all four inflammatory cytokines.In contrast,the RSD,metoprolol,and perindopril groups exhibited significant reductions in IL-6 and TGF-β1 compared to the model group(P<0.05).Histopathological analysis revealed disorganized myo-cardial fibers with interstitial fibrosis in the model group,as well asglomerular atrophy,tubular degeneration/dila-tion,and marked interstitial fibrosis with inflammatory infiltration in renal tissue.All intervention groups(RSD,metoprolol,perindopril)showed attenuated fibrotic changes(P<0.05).Tyrosine hydroxylase(TH)immunostaining showed greater sympathetic activation in the model group,which was ameliorated by all interven-tions(P<0.05).Western blot analysis confirmed up-regulated cardiac expression of TGF-β1,p-Smad2/3,α-SMA,and Collagen Ⅰ(P<0.05).These fibrotic markers were significantly downregulated in all treatment groups relative to the model group(P<0.05),with perindopril showing the most pronounced effects.Conclusions Renal sympathetic denervation alleviates cardiorenal injury in CKD rats by mitigating fibrosis and suppressing IL-6/TGF-β1-mediated inflammation.
董建;徐洁;赵亮;骆小梅
新疆医科大学第五附属医院心内科,新疆 乌鲁木齐 830000新疆医科大学第五附属医院心内科,新疆 乌鲁木齐 830000新疆医科大学第五附属医院胸外科,新疆 乌鲁木齐 830000新疆医科大学第五附属医院心内科,新疆 乌鲁木齐 830000
医药卫生
去肾交感神经术慢性肾脏病大鼠炎性因子肾脏及心肌纤维化
renal sympathetic denervationchronic kidney disease ratsinflammatory factorsrenal and myocardial fibrosis
《基础医学与临床》 2026 (2)
200-207,8
新疆维吾尔自治区自然科学基金(2021D01C441)
评论